Healthcare Equipment and Supplies
Company Overview of Ulthera, Inc.
Ulthera, Inc., a medical device company, focuses on the development and commercialization of various technologies for aesthetic and medical applications. The company provides Ulthera system, an energy-based device for use as an aesthetic treatment that non-invasively lifts the eyebrow and skin on the neck and under the chin; and transducers to image the skin tissue down to 8.0mm and deliver energy at prescribed depths. It also offers precision microblade systems for the minimally invasive treatment of cellulite in the office settings. The company sells its products to plastic surgeons, facial plastic surgeons, dermatologists, and other physician practices through its direct sales organizatio...
1840 South Stapley Drive
Mesa, AZ 85204
Founded in 2004
Key Executives for Ulthera, Inc.
Chief Executive Officer, President and Director
Vice President of Operations
Principal Accounting Officer and Controller
Compensation as of Fiscal Year 2014.
Ulthera, Inc. Key Developments
Ulthera Inc. Receives FDA Clearance for Ultherapy Décolletage Treatment
Jul 7 14
Ulthera Inc. announced that its ultrasound platform device, the Ulthera System, has received FDA clearance to non-invasively treat the chest to improve lines and wrinkles of the décolleté. The Ultherapy Décolletage Treatment utilizes the System's signature imaging and micro-focused ultrasound therapy capabilities and takes about 30 minutes to administer. The Treatment stimulates the natural formation of collagen and elastin in the skin's foundation to gradually smooth chest wrinkles. Results are visible after about three months. As with the FDA-cleared Ultherapy procedure for lifting the neck, eyebrow and under the chin, meaningful results are achieved in just one treatment, and there's no downtime or post-treatment care requirements. The Ultherapy Décolletage Treatment will be available in more than 1,500 physician practices across the United States, starting third quarter 2014. The Treatment is already cleared in more than 40 other countries worldwide and has been selectively available since 2012.
Ulthera Appoints Marshall Mohr to Board of Directors
Apr 16 14
Ulthera Inc. announced that Marshall Mohr has joined its board of directors. Mohr is currently the Senior Vice President and Chief Financial Officer at Intuitive Surgical. Mohr serves on the boards of directors of Plantronics Inc. and Pacific Biosciences of California Inc.
Ulthera System Receives Third FDA Clearance
Jan 30 14
Ulthera Inc. announced that its ultrasound platform device, the Ulthera System, has been cleared by the Food and Drug Administration (FDA) to visualize the dermal and subdermal layers of tissue during the non-invasive lifting treatment, Ultherapy. This marks the third FDA clearance the Ulthera System has received. The first two in September 2009 and October 2012, cleared the Ulthera System to non-invasively treat the face and neck with specific, first-and-only indications to lift skin on the neck, under the chin and above the brow.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 26, 2014
Most Searched Private Companies
Sponsored Financial Commentaries